Christopher J. Moreau

Christopher J. Moreau

Chief Executive Officer
Mr. Moreau is a seasoned business professional in the life sciences sector with a strong background in biotechnology research, business development and a deep expertise in the capital markets. Mr. Moreau was previously President & CEO and Director of a publicly traded company, where he raised in excess of $13 million to fund research & development for screening tests for prostate cancer, skin cholesterol and type 2 diabetes. He also has over 25 years of senior management experience in private & publicly traded company environments.
Mark Williams PhD MBA

Mark Williams PhD MBA

Chief Science Officer
Mark has 15 years of experience in drug and medical device development having repurposed 3 drugs from preclinical studies directly to positive phase II data. He was also the inventor of a recombinant protein and helped oversee its development from manufacturing into phase II trials for his previously NASDAQ traded company.

Michael Sadhra CA

Chief Financial Officer & Director
Mr. Sahdra was a Former Senior Tax Manager at KPMG and is currently aTax Partner Sadhra Chow LLP. He has Served as CFO and as Director of Numerous Public Companies.
Share via
Copy link
Powered by Social Snap